Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Clin Cancer Res. 2021 Sep 15;27(23):6405–6412. doi: 10.1158/1078-0432.CCR-21-1579

Table 2.

Adverse Events

Possibly, Probably, or Definitely Related
All AEs
Most Common No. % of Related AEs No. % of All AEs
 Injection site reaction 24 17% 24 12%
 Fatigue 19 14% 24 12%
 Flu like symptoms 10 7% 11 5%
 Lymphocyte count decreased 9 6% 11 5%
 Arthralgia 8 6% 8 4%
 Anemia 7 5% 9 4%
 Hypokalemia 5 4% 9 4%
 Platelet count decreased 5 4% 8 4%
 Headache 5 4% 5 4%
 White blood cell decreased 5 4% 5 3%

AE Gradings
 1 121 86% 172 85%
 2 19 13% 29 14%
 3 1 1% 1 0%
 4 0 0% 1 0%
 5 0 0% 0 0%